Champions Oncology

Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. The Company's team is comprised of seasoned oncology professionals passionately dedicated to working with customers to accelerate oncology drug development, improve outcomes and extend lives. Champions Oncology's core platform, the Champions TumorGraft offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
Hackensack, US
Size (employees)
60 (est)+6%
Champions Oncology was founded in 2007 and is headquartered in Hackensack, US

Key People at Champions Oncology

Joel Ackerman

Joel Ackerman

Ronnie Morris

Ronnie Morris

Scott Tobin

Scott Tobin

Misti Ushio

Misti Ushio


Champions Oncology Office Locations

Champions Oncology has offices in Hackensack, Baltimore and London
Hackensack, US (HQ)
307 1 University Plaza Dr
London, GB
2 Royal College St
Baltimore, US
602 855 N Wolfe St

Champions Oncology Data and Metrics

Champions Oncology Financial Metrics

Champions Oncology's revenue was reported to be $11.2 m in FY, 2016 which is a 26% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

11.2 m

Revenue growth (FY, 2015 - FY, 2016), %


Net income (FY, 2016)

(10.4 m)

EBIT (FY, 2016)

(10.3 m)

Market capitalization (26-May-2017)

27.8 m

Closing share price (26-May-2017)

Champions Oncology's current market capitalization is $27.8 m.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016


11.6 m8.9 m11.2 m

Revenue growth, %


Operating expense total

17.8 m22.1 m21.5 m


(6.3 m)(13.2 m)(10.3 m)

EBIT margin, %


Net Income

(7.4 m)(13.1 m)(10.4 m)
Numbers are in $, USDFY, 2014FY, 2015FY, 2016


5.9 m9.4 m

Accounts Receivable

1.3 m1.1 m1.3 m


383 k346 k443 k

Current Assets

7.6 m10.8 m4.3 m


434 k452 k618 k


669 k669 k669 k

Total Assets

8.9 m12 m5.8 m

Accounts Payable

981 k1.4 m1.9 m

Current Liabilities

3.7 m3.8 m5.3 m

Additional Paid-in Capital

43.3 m61.2 m63.9 m

Retained Earnings

(38.9 m)(52 m)(62.5 m)

Total Equity

3.2 m8.1 m238 k

Financial Leverage

2.8 x1.5 x24.3 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

(7.4 m)(13.1 m)(10.4 m)

Depreciation and Amortization

213 k214 k156 k

Accounts Receivable

(825 k)265 k(282 k)


Accounts Payable

(223 k)433 k482 k

Cash From Operating Activities

(3.4 m)(9.6 m)(6.5 m)

Purchases of PP&E

(234 k)(119 k)(322 k)

Cash From Investing Activities

(234 k)(114 k)(322 k)

Cash From Financing Activities

21 k13.2 m2 k
Y, 2016

Financial Leverage

24.3 x

Champions Oncology Market Value History

Champions Oncology Online and Social Media Presence

Champions Oncology Company Life and Culture

You may also be interested in